Surrozen - CW25

SRZNW

0.00150.00% ( 0.0000 )

Closed: Aug 11, 16:00:00 (EDT)

Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
Unusual Whales·Sep 28, 2026 at 12:01 PM
ALLR0.00%
Surrozen - CW25 | 10-K: FY2025 Revenue: USD 3.477 M
Earnings Watch·Mar 23, 2026 at 08:33 PM
SRZNW0.00%
Surrozen - CW25 | 8-K: FY2025 Revenue: USD 3.477 M
Earnings Watch·Mar 23, 2026 at 08:18 PM
SRZNW0.00%
Surrozen - CW25 | 10-Q: FY2025 Q2 Revenue: USD 983 K
Earnings Watch·Aug 8, 2025 at 08:16 PM
SRZNW0.00%
Surrozen - CW25 | 8-K: FY2025 Q2 Revenue: USD 1 M
Earnings Watch·Aug 8, 2025 at 08:13 PM
SRZNW0.00%
Surrozen - CW25 | 10-Q: FY2025 Q1 Revenue: USD 983 K
Earnings Watch·May 9, 2025 at 08:18 PM
SRZNW0.00%
Surrozen - CW25 | 8-K: FY2025 Q1 Revenue: USD 983 K
Earnings Watch·May 9, 2025 at 08:10 PM
SRZNW0.00%